Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

FDA places hold on Ziopharm CAR-T trial

June 19, 2018 Manufacturing and Production, Research and Development CAR-T, FDA, pharma, ziopharm

CAR-T is emerging as one of the most potentially exciting therapies in the industry, particularly as a beacon for the …
News
ptc

PTC Therapeutics’ results in SMA has Biogen nervous

June 19, 2018 Manufacturing and Production, Research and Development Biogen, PTC Therapeutics, biotech, drugs, pharma, pharmaceutical

Biogen currently has the only product on the market approved to treat spinal muscular atrophy (SMA), in Spinraza, and that …
News
data

Maintaining control: The rising challenges of clinical data management

June 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

From breach scandals to GDPR, data is becoming a more prominent part of our everyday lives. This holds great potential …
Feature
teva_copy

Teva axes Phase 3 trial into chronic cluster headache

June 18, 2018 Research and Development, Sales and Marketing Teva, fremanezumab, headache, pharma

With the advent of another week, there’s another trial discontinuation in the industry as Teva announces its decision to terminate …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

June 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Another busy in week in pharma has seen a number of companies release promising data on their drugs, Roche’s study …
News
allergan

Allergan appoints ex-Abbott exec in “Board refreshment” move

June 15, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, Allergan, appointment, pharma

Allergan has announced another move in its “refreshment” of its executive Board of Directors with the appointment of Thomas C …
News
wheelchair-1595802_960_720

Gene therapy offers hope for those with paralysis

June 15, 2018 Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical

Researchers at King’s College London (KCL) have made significant progress to being able to offer a treatment to those with …
News

Living with childhood dementia

June 14, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing childhood dementia, dementia, feature, patient experience, pharma

Claire Young explores her family’s journey through the diagnosis of her son George, who lives with Batten disease, a form …
Feature
roche

Roche’s Ocrevus extends time-to-wheelchair by 7 years in progressive MS patients

June 14, 2018 Research and Development Ocrevus, Roche, multiple sclerosis, pharma

Roche has lifted the curtain on more promising data at Phase 3 for its humanised anti-CD20 monoclonal antibody Ocrevus (ocrelizumab), …
News

Danger of Sanofi’s dengue vaccine confirmed in new study

June 14, 2018 Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical

A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …
News
apps_mobile

UK demand for mental health apps soars 566% since 2014

June 13, 2018 Medical Communications, Research and Development UK, apps, mental health, pharma

A new report from communications and research agencies GK Strategy and onefourzero has revealed the massive extent to which consumer …
News
vaccination-2722937_960_720

Vaccination rates in parts of US fall to dangerous levels

June 13, 2018 Research and Development anti-vax, biotech, drugs, pharma, pharmaceutical, vaccination

The anti-vaxxer movement is the scourge of meticulously researched science and yet, in certain states in the US, it seems …
News
celgene_1_02

Celgene showcases strong Otezla data in psoriatic arthritis

June 13, 2018 Research and Development Celgene, EULAR, otezla, pharma

Celgene has seized the opportunity at the Annual European Congress of Rheumatology in Amsterdam to reveal positive new data for …
News

J&J continues to shed assets, with $2.1bn diabetes unit sale

June 13, 2018 Research and Development, Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

Just last week, Johnson & Johnson announced that it had received an offer from Fortive for its medical sterilisation unit, …
News
old_hands_stick

Investors stump up cash for anti-ageing start-up

June 12, 2018 Research and Development, Sales and Marketing Juvenescence, biotech, drugs, pharma, pharmaceutical

Defeating the ageing process is a pie-in-the-sky idea that has resulted, so far, in a rich vein of parody rather …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025